Grants

Dissecting mechanisms of radio resistance associated with p53 mutations in DIPG

2022 New Investigator Grant

Zach Reitman, Duke University

Exploring copper chelation as a novel epigenetic therapeutic strategy for DIPG

2022 New Investigator Grant

Orazio Vittorio, University of New South Wales

Targeting the electrical vulnerabilities of DIPG by modulating the neuronal microenvironment

2022 New Investigator Grant

Humsa Venkatesh, The Brigham and Women's Hospital

A clinically translatable nanotherapeutic approach to enhance BBB drug delivery in DIPG

2022 Game Changer Grant

Praveen Raju, Icahn School of Medicine at Mount Sinai

Oren Becher

Development of a Comprehensive Direct Drug Delivery Platform for the Treatment of Diffuse Midline Glioma

2022 Game Changer Grant

Mark Souweidane, Weill Cornell Medical College

Targeting Diffuse Midline Gliomas with Rational Combination Therapy

2022 Game Changer Grant

Richard Lu, University of Cincinnati

Advancing data analyses of DMG tumors

2022 Special Project Grant

DMG-ACT — Building a Discovery Engine Around the Trial

2022 Special Project Grant

Sabine Mueller, Pediatric Neuro-Oncology Consortium (PNOC)

Javad Nazarian

Carl Koschmann

Co-funded by Zatkoff Family Legacy Fund

Neuro-Immuno-Oncology Fellowship & CAR T Research Expansion

2022 Special Project Grant

Michelle Monje, Stanford University

Co-funded by Austin Strong Foundation, Storm the Heavens Fund, SoSo Strong Pediatric Brain Tumor Foundation and Elle's Angels Foundation

Targeted Protein Degradation of LSD1 as a Therapeutic Strategy in DIPG

2022 Post-doctoral Fellowship Grant

Andrew Groves, Dana Farber Cancer Institute

Mentors: Mariella Filbin